Perfil
Thomas E.
Jenkins is the founder of Elysium Therapeutics, Inc., founded in 2013, where the title held is Chief Scientific Officer.
Former job includes Chief Scientific Officer & Vice President-Research at Signature Therapeutics, Inc. Education history includes a doctorate from Stanford University and an undergraduate degree from the University of Akron.
Cargos activos de Thomas Jenkins
| Empresas | Cargo | Inicio |
|---|---|---|
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Fundador | 01/01/2013 |
Antiguos cargos conocidos de Thomas Jenkins.
| Empresas | Cargo | Fin |
|---|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Director Técnico/Científico/I+D | - |
Formación de Thomas Jenkins.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Akron
University of Akron Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Jenkins
















